Tolterodine

Therapeutic analysis of tolterodine for the treatment of 26 cases with overactive bladder in female

托特罗定治疗女性膀胱过度活动症26例疗效分析

Clinical Report of Tolterodine on the Treatment of Detrusor Hyperreflexia in Patients having Spinal Cord Injury

托特罗定治疗脊髓损伤所致逼尿肌反射亢进的临床报道

Clinical Effect of 34 Patients with Serious Bladder Spasm Treated with Tolterodine

托特罗定治疗顽固性膀胱痉挛34例

A Clinical Study of Domestic Tolterodine Tartrate Tablets for Urinary Bladder Hyperactivity

国产酒石酸托特罗定片治疗膀胱过度活动症的临床研究

Clinical Evaluation on the Efficacy and Safety of Tolterodine in the Treatment for Overactive Bladder

托特罗定对膀胱活动过度疗效及安全性临床评价

OBJECTIVE To prepare the tolterodine osmotic pump tablet and study its release profiles in vitro .

目的制备酒石酸托特罗定渗透泵片，考察其体外释药特性。

Use of tolterodine in children with daytime urinary freqency syndrome

托特罗定治疗儿童日间尿频症疗效观察

Tolterodine in the Treatment of Bladder Overactivity after Prostatectomy 20 Patients

托特罗定治疗前列腺术后膀胱过度活动症20例

OBJECTIVE : To evaluate the efficacy and safety of tolterodine in the treatment of overactive bladder .

目的：评价国产托特罗定治疗膀胱活动过度的疗效和安全性。

Conclusion Naftopidil and tolterodine tartrate could be an effective therapeutic method for patients with OAB .

结论萘哌地尔加舍尼亭联合应用可作为女性膀胱过度活动症的一种有效治疗手段。

Objective To compare the curative effect of sacral nerve electrical stimulation and Tolterodine for female overactive bladder .

目的比较电刺激骶神经与托特罗定治疗女性特发性膀胱过度活动症（IOAB）的疗效。

OBJECTIVE : To study the therapeutic effect and safety of domestic tolterodine tartrate in treating patients with urinary bladder overactivity .

目的：研究国产酒石酸托特罗定片治疗膀胱过度活动症的疗效和安全性。

The structure - activity relationships of tolterodine derivatives were summarized . On the basis of these theories , ten new compounds were synthesized .

在总结托特罗定及其衍生物构效关系的基础上，设计并合成了十个未见文献报道的新化合物。

Objective : To evaluate the efficacy of tolterodine on bladder spasm caused by the indwelling catheter after prostate operation .

目的：评价托特罗定（tolterodine）治疗前列腺术后留置导尿致膀胱痉挛的疗效。

There are significant difference among the dissolution parameters of tolterodine tartrate tablets of three different pharmaceutical factories ( P < 0.01 ) .

3个不同厂家溶出参数有显著性差异（P<0.01）。

Combination of Tolterodine and Tamsulosin for Benign Prostatic Hyperplasia

托特罗定和坦索罗辛联合治疗良性前列腺增生

Comparison of Effect Between the Treatment of Tolterodine Combined with Naftopidil and of Tolterodine Alone on Female Overactive Bladder

单用托特罗定与联合萘哌地尔治疗女性膀胱过度活动症的疗效比较

Methods From January 2004 to June 2005 , 26 cases of female patients with overactive bladder received treatment with tolterodine were analyzed retrospectively and literature review .

方法回顾性分析采用托特罗定治疗26例女性膀胱过度活动症患者的临床资料，并结合文献复习。

Tamsulosin combined with tolterodine tartrate in the treatment of patients with somnipathy pertained to severe nocturia

坦索罗辛联合舍尼亭治疗严重尿频相关性睡眠障碍的疗效观察

The control group was treated with tartrate Tolterodine stator ,( the trade name of which is Sheniting ) 2mg each time , twice a day .

对照组应用酒石酸托特罗定片（商品名：舍尼亭）2mg，2次/日，两组疗程均为2周。

Methods : The optimum condition for chiral separation of tolterodine was selected through exploring factors that affect chiral separation : the type and concentration of cyclodextrin , the pH and concentration of buffer .

方法：通过探讨环糊精的种类、浓度、缓冲液的浓度、pH值对分离的影响，选择手性分离的最佳条件。

Conclusion : Acupuncture , Chinese medicine , Western medicine combined the three clinical efficacy is superior to traditional Chinese medicine alone ( retention of urine will shu ) or the M receptor blocker ( tolterodine ) .

结论：针刺、中药、西药三者合用，临床疗效明显优于针刺加中药（癃必舒片）或针刺加M受体阻滞剂（托特罗定）治疗。

Tolterodine for Bladder Overactivity

治疗膀胱过度活动症的新药托特罗定

However , China is currently an ageing society , with the increasing number of elderly patients with bladder excessive activity symptoms . These symptoms will reach a great number and also will produce great social benefits and economic benefits when studying the Tolterodine tartrate .

而中国目前正在步入老龄化社会，随着老年人数量不断增加，膀胱过度活动症状患者将越来越多，研制酒石酸托特罗定将产生巨大的社会效益和经济效益。

Results Complications of the procedure were as follows . Bladder spasms occurred in 27 cases ( accompanying hemorrhage in 2 cases and urge incontinence in 6 cases ), and the symptoms disappeared after patient-controlled intravenous analgesia and M-receptor blocker ( tolterodine ) .

结果膀胱痉挛27例，其中有2例合并出血，6例合并急迫性尿失禁，使用微量静脉自控镇痛泵及M-受体阻滞剂后症状消失。